Chiral Inhibition of Rivaroxaban Derivatives Towards UDP-Glucuronosyltransferase (UGT) Isoforms-Reference-Cited by-同舟云学术

Chiral Inhibition of Rivaroxaban Derivatives Towards UDP-Glucuronosyltransferase (UGT) Isoforms

Published:2015-10-01 Issue:12 Volume:27 Page:936-943
ISSN:0899-0042
Container-title:Chirality
language:en
Short-container-title:Chirality

Author:

Yao Zhuhua¹,Liu Yong-Zhe²,Ma Ai-Lun³,Wang Shu-Fen²,Lu Dan⁴,Hu Cui-Min⁵,Zhang Yan-Yan⁶,Wang Haina⁷,Hu Lingyun⁸,Deng Jun³⁹,Yang Kun²,Fang Zhong-Ze²

Affiliation:

1. Department of Cardiology; Tianjin Union Medicine Centre; 300121 Tianjin People's Republic of China

2. Department of Toxicology, School of Public Health; Tianjin Medical University; Tianjin People's Republic of China

3. School of Pharmaceutical Science and Technology, Key Laboratory for Modern Drug Delivery & High-Efficiency; Tianjin University; Tianjin People's Republic of China

4. Department of Immunology, Tianjin Key Laboratory of Cellular and Molecular Immunology; Tianjin Medical University; Tianjin People's Republic of China

5. Tianjin Life Science Research Center, Department of Microbiology, School of Basic Medical Sciences; Tianjin Medical University; Tianjin People's Republic of China

6. Joint Center for Translational Medicine, Dalian Institute of Chemical Physics; Chinese Academy of Sciences and First Affiliated Hospital of Liaoning Medical University; Dalian People's Republic of China

7. College of Pharmaceutical Sciences; Shandong University; Jinan People's Republic of China

8. Shandong Cancer Hospital and Institute; Shandong People's Republic of China

9. Collaborative Innovation Center of Chemical Science and Engineering; Tianjin University; Tianjin People's Republic of China

Publisher

Wiley

Subject

Organic Chemistry,Spectroscopy,Drug Discovery,Pharmacology,Catalysis,Analytical Chemistry

Reference22 articles.

1. Effect of BAY 59-7939-a novel, oral, direct factor Xa inhibitor-on clot-bound factor Xa activity in vitro;Depasse;J Thromb Haemost,2005

2. Discovery of the novel antithrombotic agent 5-chloro-N-({(5S)-2-oxo-3- [4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl} methyl) thiophene- 2-carboxamide (BAY 59-7939): an oral, direct factor Xa inhibitor;Roehrig;J Med Chem,2005

3. Metabolism and excretion of rivaroxaban, an oral, direct factor Xa inhibitor, in rats, dogs, and humans;Weinz;Drug Metab Dispos,2009

4. Co-administration of rivaroxaban with drugs that share its elimination pathways: pharmacokinetic effects in healthy subjects;Mueck;Br J Clin Pharmacol,2013

5. Structure-inhibition relationship of ginsenosides towards UDP-glucuronosyltransferases (UGTs);Fang;Toxicol Appl Pharmacol,2013

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structure and Protein–Protein Interactions of Human UDP-Glucuronosyltransferases;Frontiers in Pharmacology;2016-10-24

2. Inhibition of UDP-Glucuronosyltransferase (UGT) Isoforms by Arctiin and Arctigenin;Phytotherapy Research;2016-05-04